KLP Kapitalforvaltning AS Buys 800 Shares of Revvity Inc. $RVTY

KLP Kapitalforvaltning AS boosted its holdings in shares of Revvity Inc. (NYSE:RVTY) by 1.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 45,100 shares of the company’s stock after acquiring an additional 800 shares during the period. KLP Kapitalforvaltning AS’s holdings in Revvity were worth $4,362,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. HB Wealth Management LLC lifted its holdings in Revvity by 4.8% during the first quarter. HB Wealth Management LLC now owns 2,494 shares of the company’s stock worth $264,000 after acquiring an additional 114 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in Revvity by 21.2% during the first quarter. Farther Finance Advisors LLC now owns 796 shares of the company’s stock worth $83,000 after acquiring an additional 139 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in Revvity by 25.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company’s stock worth $73,000 after acquiring an additional 140 shares in the last quarter. Banque Transatlantique SA lifted its holdings in Revvity by 19.4% during the first quarter. Banque Transatlantique SA now owns 925 shares of the company’s stock worth $90,000 after acquiring an additional 150 shares in the last quarter. Finally, Signaturefd LLC lifted its holdings in Revvity by 9.7% during the first quarter. Signaturefd LLC now owns 1,830 shares of the company’s stock worth $194,000 after acquiring an additional 162 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors.

Revvity Price Performance

NYSE:RVTY opened at $88.36 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.75 and a current ratio of 3.33. The stock’s 50-day simple moving average is $88.08 and its 200 day simple moving average is $92.93. The company has a market cap of $10.26 billion, a P/E ratio of 37.44, a P/E/G ratio of 3.06 and a beta of 0.98. Revvity Inc. has a 52-week low of $81.36 and a 52-week high of $129.50.

Revvity (NYSE:RVTY) last released its earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. The business had revenue of $720.28 million for the quarter, compared to the consensus estimate of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.Revvity’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.22 earnings per share. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, sell-side analysts forecast that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s payout ratio is currently 11.86%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 3rd. Stifel Nicolaus cut their price target on Revvity from $120.00 to $110.00 and set a “hold” rating on the stock in a report on Tuesday, July 29th. Barclays cut their price target on Revvity from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Thursday, October 2nd. Evercore ISI cut their price target on Revvity from $108.00 to $106.00 and set an “outperform” rating on the stock in a report on Tuesday. Finally, Raymond James Financial restated an “outperform” rating and issued a $115.00 price target (down from $120.00) on shares of Revvity in a report on Tuesday, July 29th. Ten analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Revvity has an average rating of “Moderate Buy” and an average price target of $117.93.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.